Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ormalvi. Always confirm against the full prescribing information.
100 interactions
Acetylsalicylic acid
Acetylsalicylic acid may decrease the excretion rate of Diclofenamide which could result in a higher serum level.
Level 1 evidence
Alfentanil
The therapeutic efficacy of Diclofenamide can be decreased when used in combination with Alfentanil.
Level 2 evidence
Aminosalicylic acid
The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Diclofenamide.
Level 2 evidence
Amobarbital
Amobarbital may increase the hypotensive activities of Diclofenamide.
Level 2 evidence
Amphetamine
Diclofenamide may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Level 2 evidence
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Diclofenamide.
Level 2 evidence
Benzhydrocodone
The therapeutic efficacy of Diclofenamide can be decreased when used in combination with Benzhydrocodone.
Level 2 evidence
Benzphetamine
Diclofenamide may decrease the excretion rate of Benzphetamine which could result in a higher serum level.
Level 2 evidence
Benzylpenicillin
Diclofenamide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.
Level 1 evidence
Bisacodyl
The risk or severity of dehydration can be increased when Diclofenamide is combined with Bisacodyl.
Level 2 evidence
Bismuth subsalicylate
The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Diclofenamide.
Level 2 evidence
Brinzolamide
The risk or severity of adverse effects can be increased when Brinzolamide is combined with Diclofenamide.
Level 2 evidence
Enter your NPI to unlock 1 major interaction for Ormalvi
Ormalvi (Dichlorphenamide) has 667 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ormalvi (Dichlorphenamide) has 7 major, 135 moderate, and 525 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ormalvi. Always confirm against the full prescribing information.